Governance
How Aleris Group is owned, led and held to account.
Board, management and ownership
Board of Directors
Nine members, of whom two are employee representatives. The board meets eight times a year.
Group Management
The CEO and eight group functions, including a Chief Medical Officer with an independent reporting line.
Ownership
Aleris Group is owned by Triton. Ownership structure and holdings are set out in the annual report.
Who is accountable for clinical quality
Clinical accountability does not run through the commercial line. The Chief Medical Officer reports to the board, not to the country managers whose results are being reviewed.
The CMO owns clinical standards across the group, chairs the medical advisory board and has the authority to suspend an activity at any unit without commercial consultation.
Every adverse event is reported internally and, where the law requires it, to the national supervisory authority — lex Maria in Sweden, the corresponding duty in Norway and Denmark. Reports are reviewed by the CMO and summarised annually.
Senior specialists from each business area review outcome data quarterly, and set the volume thresholds below which a unit stops offering a procedure.
Financial statements are audited annually. Clinical quality is subject to the supervisory authorities of each country and to the accreditation regimes that apply to each speciality.
Report a concern, including anonymously.
Anyone — employee, patient, supplier or bystander — can report a suspected irregularity through our external whistleblowing channel.
The channel is operated by an independent third party. Reports reach a named group of three people, none of whom sit in the operational line. You can stay anonymous and still receive answers through the channel; retaliation against a reporter is itself a dismissible offence.